CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients	Acute Myeloid Leukemia in Children	Recruiting	Phase 2	2025-08-05		NCT06262438

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daiichi Sankyo	144
Princess Maxima Center for Pediatric Oncology	20

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Princess Máxima Center for pediatric oncology	Utrecht	Netherlands	4

Clinical trials